Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Women’s Health Diagnostics Market: By Type, By Application and Geography
Women’s Health Diagnostics Market size was valued at US$ 26,712.3 million in 2023 and projected to reach US$ 44,434.5 million by 2030 and poised to grow at 7.35% CAGR from 2024-2030. the increased prevalence of infectious disorders among women, such as hepatitis and urinary tract infections, is expected to fuel growth over the projection period. Advances in medical science provide lucrative chances to combat women-specific problems such as infectious illnesses, osteoporosis, and breast cancer.
Study Period
2024-2030Base Year
2023CAGR
7.35%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The market is expected to grow rapidly due to the rising prevalence of chronic and lifestyle-related disorders, the growing number of imaging and diagnostic centres, the increased adoption of point-of-care and rapid diagnostic tests, as well as player collaborations and partnerships. The growing prevalence of diseases such as breast cancer, ovarian and cervical cancer, autoimmune diseases, and infertility among women need thorough diagnosis. Furthermore, rising stress levels among women are increasing the burden of numerous illnesses such as obesity, the danger of drug abuse, and increased alcohol consumption, all of which contribute to infertility. For example, data updated by the Census Bureau in April 2022 showed that fertility rates among women aged 20 to 24 fell by 43% in recent years, with only 66.59 births per 1,000 women in that age range, indicating a 42.79% fall in fertility over the previous decades. Furthermore, according to research released and amended by the National Institutes of Health in January 2023, nearly 11% of women of reproductive age in the United States, ranging from 18 to 35 years old, have encountered fertility issues in recent years. As the occurrence of infertility among women rises, so does the demand for fertility testing and diagnosis in emerging nations, which is expected to drive market expansion throughout the forecast period.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 26,712.3 million |
Market Size in 2030 |
US$ 44,434.5 million |
Market CAGR |
7.35% |
By Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
The global women’s health diagnostics market size was valued at US$ 26,712.3 million in 2023 and is projected to grow at a CAGR of 7.35% by 2030.
The market is expected to grow rapidly due to the rising prevalence of chronic and lifestyle-related disorders, the growing number of imaging and diagnostic centers, the increased adoption of point-of-care and rapid diagnostic tests, as well as player collaborations and partnerships.
Due to the rising incidence of breast cancer, demand for breast cancer tests is increasing in both emerging and developed countries, which is likely to drive segment growth over the forecast period.
Market research is segmented based on type, application, and region.
North America is estimated to dominate with the highest CAGR over the forecast period.
1.Executive Summary |
2.Global Women’s Health Diagnostics Market Introduction |
2.1.Global Women’s Health Diagnostics Market - Taxonomy |
2.2.Global Women’s Health Diagnostics Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.Region |
3.Global Women’s Health Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Women’s Health Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Women’s Health Diagnostics Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Diagnostic Device |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Diagnostic Tests |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Women’s Health Diagnostics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Breast Cancer |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Infectious Disease |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Osteoporosis |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. STD |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Other |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Women’s Health Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Diagnostic Device |
8.1.2.Diagnostic Tests |
8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Breast Cancer |
8.2.2.Infectious Disease |
8.2.3.Osteoporosis |
8.2.4.STD |
8.2.5.Other |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Diagnostic Device |
9.1.2.Diagnostic Tests |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Breast Cancer |
9.2.2.Infectious Disease |
9.2.3.Osteoporosis |
9.2.4.STD |
9.2.5.Other |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Diagnostic Device |
10.1.2.Diagnostic Tests |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Breast Cancer |
10.2.2.Infectious Disease |
10.2.3.Osteoporosis |
10.2.4.STD |
10.2.5.Other |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Diagnostic Device |
11.1.2.Diagnostic Tests |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Breast Cancer |
11.2.2.Infectious Disease |
11.2.3.Osteoporosis |
11.2.4.STD |
11.2.5.Other |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Women’s Health Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Diagnostic Device |
12.1.2.Diagnostic Tests |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Breast Cancer |
12.2.2.Infectious Disease |
12.2.3.Osteoporosis |
12.2.4.STD |
12.2.5.Other |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Abbott Laboratories |
13.2.2.GE Healthcare |
13.2.3.Mankind Pharma |
13.2.4.Quest Diagnostic Inc |
13.2.5.Siemens |
13.2.6.BD Company |
13.2.7.Hologic Inc |
13.2.8.Procter & Gamble Co |
13.2.9.Biome Rieux SA |
13.2.10.Koninklijke Philips NV |
13.2.11.Carestream Health |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players